Millennium Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.22M | Buy |
201,172
+47,932
| +31% | +$767K | ﹤0.01% | 2361 |
|
|
2025
Q1 | $2.62M | Buy |
153,240
+6,143
| +4% | +$105K | ﹤0.01% | 2414 |
|
|
2024
Q4 | $3.64M | Sell |
147,097
-229,410
| -61% | -$5.68M | ﹤0.01% | 2194 |
|
|
2024
Q3 | $10.7M | Buy |
376,507
+101,155
| +37% | +$2.88M | 0.01% | 1513 |
|
|
2024
Q2 | $7.27M | Sell |
275,352
-183,675
| -40% | -$4.85M | ﹤0.01% | 1673 |
|
|
2024
Q1 | $14.8M | Sell |
459,027
-212,374
| -32% | -$6.86M | 0.01% | 1238 |
|
|
2023
Q4 | $28.3M | Buy |
671,401
+12,769
| +2% | +$538K | 0.01% | 831 |
|
|
2023
Q3 | $25.3M | Buy |
658,632
+109,486
| +20% | +$4.2M | 0.01% | 826 |
|
|
2023
Q2 | $10.4M | Sell |
549,146
-533,756
| -49% | -$10.1M | 0.01% | 1429 |
|
|
2023
Q1 | $16.8M | Buy |
1,082,902
+1,000,461
| +1,214% | +$15.5M | 0.01% | 1062 |
|
|
2022
Q4 | $1.46M | Sell |
82,441
-162,816
| -66% | -$2.89M | ﹤0.01% | 2898 |
|
|
2022
Q3 | $1.37M | Sell |
245,257
-88,296
| -26% | -$493K | ﹤0.01% | 3133 |
|
|
2022
Q2 | $1.3M | Sell |
333,553
-262,727
| -44% | -$1.02M | ﹤0.01% | 3230 |
|
|
2022
Q1 | $3.29M | Buy |
596,280
+258,312
| +76% | +$1.42M | ﹤0.01% | 2686 |
|
|
2021
Q4 | $2.88M | Buy |
337,968
+130,042
| +63% | +$1.11M | ﹤0.01% | 2669 |
|
|
2021
Q3 | $1.81M | Sell |
207,926
-288,497
| -58% | -$2.51M | ﹤0.01% | 3136 |
|
|
2021
Q2 | $5.25M | Buy |
496,423
+66,461
| +15% | +$702K | ﹤0.01% | 2086 |
|
|
2021
Q1 | $6.9M | Buy |
429,962
+8,778
| +2% | +$141K | ﹤0.01% | 1763 |
|
|
2020
Q4 | $19.5M | Sell |
421,184
-152,279
| -27% | -$7.03M | 0.01% | 800 |
|
|
2020
Q3 | $20.2K | Buy |
573,463
+116,329
| +25% | +$4.09K | 0.02% | 573 |
|
|
2020
Q2 | $11.1M | Buy |
457,134
+58
| +0% | +$1.41K | 0.02% | 886 |
|
|
2020
Q1 | $7.11M | Buy |
+457,076
| New | +$7.11M | 0.02% | 842 |
|